Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Beats Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) came out with a quarterly loss of $0.4 per share versus the Zacks Consensus Estimate of a loss of$ 0.38. This compares to a loss of $0.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -5.26%. A quarter ago, it was expected that this company would post a loss of$ 0.51 per share when it actually produced a loss of $0.5, delivering a surprise of +1.96%.Over the last four quarters, the comp ...